Chemical Structure : BAY-8002
CAS No.: 724440-27-1
Catalog No.: PC-35589Not For Human Use, Lab Use Only.
BAY-8002 is a novel potent, selective, orally available monocarboxylate transporter 1 (MCT1) inhibitor (Kd=7.9 nM), inhibits cellular lactate uptake in DLD-1 cells with IC50 of 8 nM.
Packing | Price | Stock | Quantity |
---|---|---|---|
10 mg | $128 | In stock | |
25 mg | $218 | In stock | |
50 mg | $348 | In stock | |
100 mg | $558 | In stock | |
250 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
BAY-8002 is a novel potent, selective, orally available monocarboxylate transporter 1 (MCT1) inhibitor (Kd=7.9 nM), inhibits cellular lactate uptake in DLD-1 cells with IC50 of 8 nM.
BAY-8002 displays no significant activity against in MCT4 expressing cells.
BAY-8002 inhibits cellular SNARF-5 fluorescence change with an IC50 of 85 nM in MCT1-expressing DLD-1 cells and displays excellent selectivity against MCT4 (IC50 >50 uM in EVSA-T cells).
BAY-8002 inhibits lactate uptake in MCT2-expressing oocytes, with ~5-fold lower potency compared to the MCT1 isoform.
BAY-8002 significantly increases intratumor lactate levels and transiently modulates pyruvate levels, inhibits Raji (IC50=0.67 uM) but not WSU-DLCL2 tumor growth.
M.Wt | 415.844 | |
Formula | C20H14ClNO5S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
2-(2-chloro-5-(phenylsulfonyl)benzamido)benzoic acid |
1. Quanz M, et al. Mol Cancer Ther. 2018 Aug 16. pii: molcanther.1253.2017.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright